CW August 2004
Volume 13Issue Number 8 August 2004 ISSN 10593802 In Advanced Prostate and Lung Cancer, the Cost of Skeletal-Related Events May Justify Preventive TreatmentThe full economic impact of bone metastases, both in prostate and lung cancer patients, may justify early intervention with intravenous bisphosphonates, according to two analyses presented at the 40th Annual Meeting of the American Society of Clinical Oncology.
Go to Previous Page Go to Next Page Source & Additional Reading 40th Annual Meeting of the American Society of Clinical Oncology. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW August 2004Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
